U.S. health advisers have narrowly endorsed an antiviral drug from Merck to treat COVID-19.

美国卫生顾问以微弱优势批准了默克公司的一种抗病毒药物，以治疗新冠肺炎。

The team from Oxford University are testing an antiviral drug called tecovirimat to see if it speeds up patients' recovery.

来自牛津大学的研究小组正在测试一种名为 tecovirimat 的抗病毒药物，看看它是否能加快患者的康复。